Skip to main content
Home
BE
  • nl
  • fr
  • en
  • Get to know Sciensano
    • About Sciensano
    • Sciensano in figures
    • Sciensano's structure
    • Contact Sciensano
    • Our commitment to quality, health, safety and environment
    • Partnerships
    • Emergency and Response
    • Working / doing an internship at Sciensano
    • Jobs
    • Values and standards
    • History of Sciensano
    • 2021 Annual Report of Sciensano
  • Areas of expertise
    • List of health topics from A-Z
    • Health and disease monitoring
    • Animal Health
    • Effectiveness of safety of vaccines, medicines and health products - Quality of medical laboratories
    • Food consumption and food safety
    • Health and environment
    • Quality of healthcare
  • Our services
    • Analysis request
    • Data collection
    • External quality assessment
    • Control and Safety Assessment
    • Licensing
    • Health Information
    • Health Threats
    • Projects
    • Reports & Publications
  • Press Corner

Search form

  1. Home
  2. NGS

Other projects with this keyword

  • Next-Generation Sequencing in (hemato)-oncology [ ComPerMed ]
  • National infrastructure for genomic-epidemiologic surveillance of infectious diseases [ HERA-BE-Incubator-2021 ]
  • Fast Antimicrobial Resistance and Mobile-Element Detection using metagenomics for animal and human on-site tests [ FARMED ]
  • Development of next generation sequencing data analysis tools in support of a fast response for public health and food chain safety [ NeXSplorer.iph ]
  • Monitoring of the whole genome sequencing (WGS) data of SARS-CoV-2 genomes to identify variants and their impact on detection methods [ COVIPRIM_VAR2 ]
  • Development and implementation of a Belgian platform for the generation and use of “whole genome sequencing” (WGS) data for outbreak investigation, with the for human pathogenic Shiga-toxin producing Escherichia coli (STEC) as case study [ StEQIDEMIC.be ]
  • Transversal platform of Biotechnology and Molecular Biology [ BIOTECH Platform ]
  • Characterisation of antimicrobial resistance in bacteria, including plasmids, through the development of a generic NGS-based workflow and adapted databases [ AMRSeq ]
  • Development and application of next-generation sequencing (NGS) and metagenomics to improve influenza surveillance and pandemic preparedness in Belgium [ NGS Influenza ]

QR code

QR code for this page URL

Sciensano info

 +32 2 642 51 11
 info@sciensano.be
 contact
 +32 2 642 50 01

Postal address

Sciensano
Rue Juliette Wytsmanstraat 14
1050 Brussels, Belgium

About us
Sciensano jobs
Responsibility and privacy
Privacy notice

WIV-ISP Logo